NXRA yields 200000000.00% · ABBV yields 3.09%● Live data
📍 NXRA pulled ahead of the other in Year 1
Combined, NXRA + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NXRA + ABBV for your $10,000?
Nextera Enterprises, Inc., through its subsidiary, W Lab Acquisition Corp., develops and markets consumer products that offer solutions to niche personal care needs. It offers cosmetic remedies for spider veins, dark circles, blotchy skin, bruises, stretch marks, sun spots, at home microdermabrasion kit, and deep facial lines under the Vita-K Solution brand. The company, under the DermaFreeze365 brand, offers instant line relaxing formula as an anti-line and wrinkle cream for the face, neck and chest, and lip areas; and offers two anti-aging compounds: Gamma-Amino Butyric Acid, a new ingredient in modern skin care technology, and BioxiLift, which produces a cumulative reduction in the appearance of fine lines and wrinkles. It also offers Ellin LaVar Textures brand products to address the health and condition of hair and scalp, including OptiMoist Shampoo, SatinSoft Conditioner, LiquidGlass, PenetratingBalm, ReconstructMasque, ThermMist, NourishOil, DetangleMist, LiquidMotion, InstantShine, ScalpRx, and NaturalControl. In addition, the company offers dry shampoo product in an aerosol spray formulation under the Psssssst brand; and a recipe for ageless skin under the Skin Appetit brand. It also markets its products at retail under the Heavy Duty, 40 Carrots, Virtual Laser, Stoppers-4, Bath Lounge, Vita-C2, Firminol-10, and TurboShave brands. The company markets its products to drug, food, and mass-merchandise retail chains through a team of internal sales managers, as well as a sales force of independent sales representatives. Its customers include chain drugstores, mass volume retailers, national mass merchandisers, and grocery chains. Nextera Enterprises, Inc. was founded in 1997 and is based in Panorama City, California.
Full NXRA Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.